These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37209573)

  • 21. Tumour Infiltrating Lymphocytes (TILs) and immune composition in breast cancer patients from Kenya: Spatial distributions and associations with risk factors and tumour characteristics.
    Sayed S; Koka H; Abubakar M; Gardner K; Salgado R; Moloo Z; Caban-Ureña AB; Rosen D; Castro P; Saleh M; Shaikh AJ; Shah J; Figueroa J; Makokha F; Ha HK; Wang Z; Magangane P; Naidoo R; Ngundo V; Yang XR; Govender D
    Breast Cancer Res Treat; 2023 Jun; 199(2):401-413. PubMed ID: 37010652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new method for evaluating tumor-infiltrating lymphocytes (TILs) in colorectal cancer using hematoxylin and eosin (H-E)-stained tumor sections.
    Iseki Y; Shibutani M; Maeda K; Nagahara H; Fukuoka T; Matsutani S; Kashiwagi S; Tanaka H; Hirakawa K; Ohira M
    PLoS One; 2018; 13(4):e0192744. PubMed ID: 29698402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy.
    Denkert C; von Minckwitz G; Darb-Esfahani S; Lederer B; Heppner BI; Weber KE; Budczies J; Huober J; Klauschen F; Furlanetto J; Schmitt WD; Blohmer JU; Karn T; Pfitzner BM; Kümmel S; Engels K; Schneeweiss A; Hartmann A; Noske A; Fasching PA; Jackisch C; van Mackelenbergh M; Sinn P; Schem C; Hanusch C; Untch M; Loibl S
    Lancet Oncol; 2018 Jan; 19(1):40-50. PubMed ID: 29233559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of intra-tumoral tumour-infiltrating lymphocytes and neutrophil-to-lymphocyte ratio is an independent prognostic factor in non-small cell lung cancer.
    Dirican N; Karakaya YA; Gunes S; Daloglu FT; Dirican A
    Clin Respir J; 2017 Nov; 11(6):789-796. PubMed ID: 26619201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prognostic value of tumor-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: a systematic review and meta-analysis.
    Zhao Y; Ge X; He J; Cheng Y; Wang Z; Wang J; Sun L
    World J Surg Oncol; 2019 May; 17(1):85. PubMed ID: 31118034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer.
    Li Y; Liang L; Dai W; Cai G; Xu Y; Li X; Li Q; Cai S
    Mol Cancer; 2016 Aug; 15(1):55. PubMed ID: 27552968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel tumour-infiltrating lymphocyte-related risk stratification based by flow cytometry for patients with de novo angioimmunoblastic T cell lymphoma.
    Zhu Q; Deng X; Yao W; Chen Z; Ye Y; Gao L; Zhang W; Liu W; Zhao S
    Ann Hematol; 2021 Mar; 100(3):715-723. PubMed ID: 33389024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Prognostic Significance of the Tumor-infiltrating Programmed Cell Death-1
    Shibutani M; Maeda K; Nagahara H; Fukuoka T; Nakao S; Matsutani S; Hirakawa K; Ohira M
    Anticancer Res; 2017 Aug; 37(8):4165-4172. PubMed ID: 28739701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between primary colorectal cancer histology and the histopathological growth patterns of corresponding liver metastases.
    Höppener DJ; Stook JPL; Galjart B; Nierop PMH; Nagtegaal ID; Vermeulen PB; Grünhagen DJ; Verhoef C; Doukas M;
    BMC Cancer; 2022 Aug; 22(1):911. PubMed ID: 35996090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive and prognostic role of tumour-infiltrating lymphocytes in breast cancer patients with different molecular subtypes: a meta-analysis.
    Gao ZH; Li CX; Liu M; Jiang JY
    BMC Cancer; 2020 Nov; 20(1):1150. PubMed ID: 33238978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histopathological tumour microenvironment score independently predicts outcome in primary operable colorectal cancer.
    Hatthakarnkul P; Pennel K; Alexander P; van Wyk H; Roseweir A; Inthagard J; Hay J; Andersen D; Maka N; Park J; Roxburgh C; Thuwajit C; McMillan D; Edwards J
    J Pathol Clin Res; 2024 May; 10(3):e12374. PubMed ID: 38650367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PD-L1 expression in tumour-infiltrating lymphocytes is a poor prognostic factor for primary acral melanoma patients.
    Ren M; Dai B; Kong YY; Lv JJ; Cai X
    Histopathology; 2018 Sep; 73(3):386-396. PubMed ID: 29637587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumour-infiltrating lymphocytes (TILs)-related genomic signature predicts chemotherapy response in breast cancer.
    Kochi M; Iwamoto T; Niikura N; Bianchini G; Masuda S; Mizoo T; Nogami T; Shien T; Motoki T; Taira N; Tokuda Y; Doihara H; Matsuoka J; Fujiwara T
    Breast Cancer Res Treat; 2018 Jan; 167(1):39-47. PubMed ID: 28905250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumour-infiltrating lymphocytes in advanced HER2-positive breast cancer treated with pertuzumab or placebo in addition to trastuzumab and docetaxel: a retrospective analysis of the CLEOPATRA study.
    Luen SJ; Salgado R; Fox S; Savas P; Eng-Wong J; Clark E; Kiermaier A; Swain SM; Baselga J; Michiels S; Loi S
    Lancet Oncol; 2017 Jan; 18(1):52-62. PubMed ID: 27964843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PD-L1 Overexpression on Tumor-Infiltrating Lymphocytes Related to Better Prognosis of Colorectal Cancer.
    Wang JL; Yu T; Sun TT; Feng Y; Xiong H; Fang JY
    Clin Lab; 2020 Dec; 66(12):. PubMed ID: 33337839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumour infiltrating lymphocytes in oropharyngeal carcinoma: prognostic value and evaluation of a standardised method.
    De Keukeleire SJ; Vermassen T; De Meulenaere A; Deron P; Huvenne W; Duprez F; Creytens D; Van Dorpe J; Rottey S; Ferdinande L
    Pathology; 2021 Dec; 53(7):836-843. PubMed ID: 34217516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The local inflammatory response in colorectal cancer - Type, location or density? A systematic review and meta-analysis.
    Alexander PG; McMillan DC; Park JH
    Cancer Treat Rev; 2020 Feb; 83():101949. PubMed ID: 31869737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD3+ cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study.
    Laghi L; Bianchi P; Miranda E; Balladore E; Pacetti V; Grizzi F; Allavena P; Torri V; Repici A; Santoro A; Mantovani A; Roncalli M; Malesci A
    Lancet Oncol; 2009 Sep; 10(9):877-84. PubMed ID: 19656725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor-infiltrating lymphocytes in tissue material combined with systemic lymphocyte inflammation in patients with colorectal cancer.
    Jakubowska K; Koda M; Grudzińska M; Lomperta K; Famulski W
    Mol Clin Oncol; 2021 May; 14(5):97. PubMed ID: 33767866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased number of forkhead box P3+ tumor-infiltrating lymphocytes correlates with high preoperative albumin level and better survival in patients with stage II or III colorectal cancer.
    Wang DL; Liu YY; Gu YL; Qin Y; Ji HF; Wu LH; Qi N; Su D; Huang SH; Zhang YQ
    Tumour Biol; 2015 Jul; 36(7):5407-14. PubMed ID: 25697896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.